A sponge-like gold nanoparticle platform could deliver faster, more accurate, and less invasive ovarian cancer diagnostics.

More than two-thirds of deaths from ovarian cancer are attributable to high-grade serous carcinoma. In one particularly ...

We’re starting to understand more that endometrial cancer harbors a number of cell surface markers, including folate receptor ...

Suvemcitug combined with chemotherapy significantly improved PFS and OS in platinum-resistant recurrent ovarian cancer, nearly doubling median PFS and extending median OS. The trial demonstrated ...

Researchers at The University of Queensland have developed gold nanoparticles capable of highlighting faint cancer markers in non-invasive samples like urine, saliva, or blood. Mesoporous gold ...

An expert discusses how the biggest barriers to incorporating antibody-drug conjugates (ADCs) include lacking biomarker knowledge and how payer restrictions can be overcome through early biomarker ...

In 2022, more than 13,000 people died from ovarian cancer, according to the CDC. A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study finds. It’s the latest example of medical tests that contribute to health ...

In general, getting screened for cancer seems like the responsible thing to do, since preventing the disease is always better than treating it once it takes hold. But the latest research shows that ...